Drug intelligence / Profile preview

Propel DBM

Development stage
Unknown
Lead developer
NuVasive
Administration
Topical
01

Overview

Propel DBM is a demineralized bone matrix (DBM) product line developed by NuVasive (now a part of Globus Medical) for use in spinal fusion and other orthopedic procedures. Classified as a human-derived bone matrix implant, it is used as a bone graft substitute to fill skeletal voids or gaps that are not intrinsic to the stability of the bony structure. The product line includes various form factors such as fibers, gel, and putty, designed to meet different surgical handling requirements. Propel DBM functions through osteoconduction, providing a physical scaffold for new bone growth, and osteoinduction, utilizing the natural growth factors (such as bone morphogenetic proteins) retained within the demineralized matrix to recruit and differentiate mesenchymal stem cells into osteoblasts.

Brand names
Propel DBMPropel DBM FibersPropel DBM GelPropel DBM Gel PlusPropel DBM Putty Plus
Other names
Demineralized Bone Matrix
02

Targets

BMP (Bone morphogenetic protein family)

Beyond the preview

Go deeper on Propel DBM.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Propel DBM.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call